Navigation Links
Diabetes gene linked to degeneration of enzyme involved in Alzheimer's disease onset and progression
Date:10/12/2010

Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.

The new study provides insight into a potential mechanism that might explain the relationship between Type 2 diabetes and the onset and progression of Alzheimer's disease. Recent evidence indicates that healthy elderly subjects affected by Type 2 diabetes are twice as likely to develop Alzheimer's disease, but researchers have been unable to explain how.

"The relationship between Type 2 diabetes and Alzheimer's disease has been elusive," said Dr. Pasinetti. "This new evidence is of extreme interest, especially since approximately 60 percent of Alzheimer's disease cases have at least one serious medical condition primarily associated with Type 2 diabetes."

Using mice that were genetically engineered to have Alzheimer's disease comparable to that seen in humans, Dr. Pasinetti and colleagues found that a gene known as proliferator-activated receptor coactivator 1 (PGC-1), a key regulator of glucose currently investigated as a potential therapeutic target for Type 2 diabetes, is decreased in Alzheimer's disease. The team reports that this decrease might be causally linked to promotion of Alzheimer's disease. They found that PGC-1 promotes degradation of a specific enzyme known as beta-secretase (BACE). ACE is directly involved in the processing and eventually generation of β-amyloid, an abnormal protein highly linked to Alzheimer's disease and brain degeneration.

"Our research is the first to find that PGC-1 is a common denominator between Type 2 diabetes and Alzheimer's disease," said Dr. Pasinetti. "This discovery will have significant implications for the more than five million Americans affected by Alzheimer's disease, a number that is expected to skyrocket in the next three decades as the population ages. We look forward to continuing to research this discovery and translate it into the development of novel approaches for disease prevention and treatment."

Dr. Pasinetti and his colleagues are optimistic that if they find that PGC-1 can be manipulated pharmacologically to prevent BACE accumulation in the brain, these studies will provide important insights for the formulation of novel treatments and possible preventative strategies in Alzheimer's disease.


'/>"/>

Contact: Mount Sinai Press Office
newsnow@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related medicine news :

1. UT Southwestern study to determine whether leptin helps type 1 diabetes patients
2. Study links large waist size to higher diabetes rates among Americans
3. Patient-provider language barriers linked to worse diabetes control
4. Experts advocate realigning type 2 diabetes treatments with diseases natural history
5. Heart, kidney, diabetes and cancer MEP groups league against chronic disease to seek European commitment
6. Lifestyle intervention improves risk factors in type 2 diabetes
7. Type 1 diabetes research at UC San Diego gets $5 million boost
8. OHSU research team joins elite consortium dedicated to curing type 1 diabetes
9. Congressman to speak at meeting on diabetes and obesity
10. Drug holds promise to halt debilitating condition of diabetes
11. Immune System Genes Show Links to Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Sue Desmond-Hellmann, ... Class of 2016 to stretch the limits of human possibility in her keynote address ... p.m. in the Georgia Dome. , Drawing on her rich experience as a scientist, ...
(Date:5/3/2016)... ... May 03, 2016 , ... With the opioid epidemic ... or excessive levels of alcohol use. Alcohol and its misuse causes long-term consequences ... to the susceptibility to strokes in those 65 years and older. In addition, ...
(Date:5/3/2016)... ... 03, 2016 , ... Cosmetic surgeon Dr. Mark Youssef first introduced Voluma® to ... filler into his menu of services to give his patients as many options as ... he’s still improving his approach to ensure he stays at the forefront of the ...
(Date:5/3/2016)... ... May 03, 2016 , ... Diagnotes, a leader ... Health, a three hospital system in South Carolina, to provide its secure mobile ... technology that enhances communication, drives workflow efficiencies and improves provider and patient satisfaction,” ...
(Date:5/3/2016)... ... May 03, 2016 , ... Park Cities Pet Sitter has openings for ... the 75204, 75205, 75206, 75209, 75219, 75220, 75225, 75229, 75230, 75231 and 75235 zip ... North Dallas, Plano, Preston Hollow and Park Cities areas of the Metroplex. Candidates ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... DUBLIN , May 3, 2016 ... to pay $55 million to a woman who says ... State court awarded Gloria Ristesund $5 million ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... of accusations against the company. In February, the same ...
(Date:5/3/2016)... excited to announce the launch of its Mediceutical line of products, a line of ... of clinical conditions. Founded in 2013, Forté spent more than two years researching and ... http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)... YORK , May 2, 2016 Leading Economies with ... Ethiopia 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, ... Research, BRICS nations , which comprises of Brazil , ... and South Africa , registered the fastest GDP ... slowdown in China , recession in Brazil ...
Breaking Medicine Technology: